Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Meningococcal disease
Rotavirus
2022
Africa
Europe
Clear all
Type of publications
NITAG documentation
(33)
Systematic reviews (SYSVAC)
(27)
Topics
Available to download in languages
Regions
Africa
(23)
Europe
(37)
Americas
(40)
Eastern Mediterranean
(3)
South-East Asia
(1)
Western Pacific
(17)
Countries
Algeria
(1)
Belgium
(5)
Burkina Faso
(1)
Ethiopia
(6)
France
(10)
Germany
(2)
Ireland
(4)
Italy
(1)
Netherlands
(2)
Niger
(1)
Nigeria
(1)
Spain
(1)
Uganda
(3)
Ukraine
(1)
United Kingdom
(6)
Diseases
COVID-19
(57)
Meningococcal disease
(1)
Rotavirus
(2)
Hepatitis B
(2)
Herpes zoster
(3)
Human papillomavirus (HPV)
(5)
Influenza
(5)
Malaria
(4)
Mpox // Monkeypox
(8)
Pertussis
(1)
Pneumococcal disease
(4)
Poliomyelitis
(1)
Rabies
(1)
Typhoid
(1)
Vaccine topics
Acceptance
(19)
Coverage
(7)
Economic aspects
(1)
Efficacy/effectiveness
(1)
Ethical issues
(4)
Target population
Adolescents
(2)
Adults
(8)
All age groups
(18)
Children
(3)
Healthcare workers
(16)
Newborn
(2)
Older adults
(3)
Parents/caregivers
(3)
Pregnant women
(5)
Travellers
(1)
Publication date
2022
(60)
2024
(2)
2023
(23)
2021
(97)
2020
(20)
2019
(7)
2018
(10)
2017
(7)
2016
(7)
2015
(11)
2014
(8)
2013
(4)
2012
(1)
2011
(1)
2010
(6)
2009
(2)
2006
(5)
2001
(1)
2000
(1)
60 results found
2022
Advice of the NITAG in the context of the administration of a booster dose of COVID-19 vaccine in Niger
2022
∙
NIAC
NIAC Recommendations for additional COVID-19 Booster Vaccination
2022
∙
UNITAG
Advisory Report on the Introduction of More WHO Approved Covid-19 Vaccines In Uganda
2022
∙
Conseil Supérieur de la Santé (CSS)
Booster vaccination for children and adolescents
2022
∙
Conseil Supérieur de la Santé (CSS)
Booster vaccination for immunocompromised patients
2022
∙
Conseil Supérieur de la Santé (CSS)
COVID-19 vaccination: Autumn / Winter season 2022 – 2023 in Belgium
2022
∙
Health Council of the Netherlands
Executive summary of the Second booster vaccination against COVID-19
2022
∙
JCVI
JCVI statement on COVID-19 vaccinations in 2022: 21 February 2022
2022
∙
JCVI
JCVI statement on the adult COVID-19 booster vaccination programme and the Omicron variant
2022
∙
JCVI
JCVI statement on vaccination of children aged 5 to 11 years old
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register